The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?

E-ISSN： 2212-3911|8|2|104-113

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.2, 2013-01, pp. : 104-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 41-47

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical Methods to Analyze Adverse Events Data of Randomized Clinical Trials

By Siddiqui Ohidul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 889-899

Taylor & Francis Ltd

Access to resources Recommend Favorite

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

By Tonstad Serena

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 289-301

Adis International

Access to resources Recommend Favorite

CAN we say that modern radiologic contrast agents are safe in myasthenia gravis?

MUSCLE AND NERVE, Vol. 51, Iss. 5, 2015-05 ,pp. : 782-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

How Can We Improve Transfer of Outcomes from Randomized Clinical Trials to Clinical Practice with Disease-Modifying Drugs in Alzheimer's Disease?

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-08 ,pp. : 197-199

Karger

Access to resources Recommend Favorite